RD Saúde, formerly Raia Drogasil, is a chain of pharmacies with the Raia, Drogasil and Onofre e-commerce brands, selling drugs, perfumes and health services in every state of the country. It was formed in 2011 when Raia and Drogasil merged operations and was renamed RD Saúde in 2024. Branded drugs account for about 44% of prescriptions, perfumery for 24%, over-the-counter (OTC) drugs for 20% and generics for 13% (2025), all in Brazil. Control comes from a shareholder agreement between the Raia, Pipponzi and Zagottis families and GL Investimentos, with about 24.6% of the capital; about 75% of the shares are in the market.
Market capitalization, or "market cap", is the aggregate market value of a company represented in a dollar amount. Since it represents the “market” value of a company, it is computed based on the current market price (CMP) of its shares and the total number of outstanding shares.
Enterprise value (EV) measures a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt and any cash or cash equivalents on the company's balance sheet.
The enterprise value-to-revenue multiple (EV/R) is a measure of the value of a stock that compares a company's enterprise value to its revenue. EV/R is one of several fundamental indicators that investors use to determine whether a stock is priced fairly. The EV/R multiple is also often used to determine a company's valuation in the case of a potential acquisition. It's also called the enterprise value-to-sales multiple.
The enterprise value to earnings before interest, taxes, depreciation, and amortization ratio (EV/EBITDA) compares the value of a company—debt included—to the company's cash earnings less non-cash expenses. It's best to use the EV/EBITDA metric when comparing companies within the same industry or sector. Typically, when evaluating a company, an EV/EBITDA value below 10 is seen as healthy.
It follows the same logic as the EV/EBITDA indicator, but instead of EBITDA, EBIT is used, which considers non-cash D&A expenses in the company's operating result.
...and much more!